A drug with the SMILES Cc1cc(N2CCN(C)CC2)n2nc(-c3ccc(Cl)cc3)nc2n1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -77.344%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc(N2CCN(C)CC2)n2nc(-c3ccc(Cl)cc3)nc2n1
Cc1cc(N2CCN(C)CC2)n2nc(-c3ccc(Cl)cc3)nc2n1
2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine